Literature DB >> 7479524

Formation of F2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol.

M Salami1, C Galli, L De Angelis, F Visioli.   

Abstract

Oxidatively-modified low-density lipoproteins (LDL) contribute to the onset of the atherosclerotic disease. A recently discovered marker of lipid peroxidation in a series of prostaglandin F2-like compounds, the prostaglandin isomers isoprostanes, that are generated from arachidonic acid through cyclooxygenase-independent pathways following free radical injury and are endowed with potent biological activities. The incidence of cardiovascular disease in the Mediterranean area is low, possibly because of the type of fat (mainly olive oil) and other components (e.g. fruits and vegetables) of the diet. Natural antioxidants abound in this kind of diet and may also contribute to the observed protection from coronary heart disease (CHD) by retarding the formation of the atherosclerotic plaque. Olive oil, the major dietary fat in the Mediterranean countries, is rich in phenols with antioxidant properties. We thus investigated the formation of isoprostanes during in vitro LDL oxidation and tested the effect of an olive-oil-extracted phenol (i.e. hydroxytyrosol). Our data show that production of isoprostanes and other markers of lipid peroxidation occurs during LDL oxidation and is inhibited by hydroxytyrosol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479524     DOI: 10.1016/1043-6618(95)80032-8

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  12 in total

1.  Effect of the olive oil phenol hydroxytyrosol on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide.

Authors:  Luis Goya; Raquel Mateos; Laura Bravo
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

Review 2.  The mechanism and prevention of mitochondrial injury after exercise.

Authors:  Mingzhe Li; Baoan Ning; Tianhui Wang
Journal:  J Physiol Biochem       Date:  2021-03-02       Impact factor: 4.158

3.  Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Paola Di Meglio; Carlo Irace; Maria Savarese; Raffaele Sacchi; Maria Pia Cinelli; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-16       Impact factor: 3.000

4.  Use of whole cells of Pseudomonas aeruginosa for synthesis of the antioxidant hydroxytyrosol via conversion of tyrosol.

Authors:  N Allouche; M Damak; R Ellouz; S Sayadi
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

5.  Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells.

Authors:  Xiaomei Zhang; Jun Cao; Laifu Zhong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-07       Impact factor: 3.000

Review 6.  Polyphenols: benefits to the cardiovascular system in health and in aging.

Authors:  Sandhya Khurana; Krishnan Venkataraman; Amanda Hollingsworth; Matthew Piche; T C Tai
Journal:  Nutrients       Date:  2013-09-26       Impact factor: 5.717

7.  Absorption, Metabolism, and Excretion by Freely Moving Rats of 3,4-DHPEA-EDA and Related Polyphenols from Olive Fruits (Olea europaea).

Authors:  Shunsuke Kano; Haruna Komada; Lina Yonekura; Akihiko Sato; Hisashi Nishiwaki; Hirotoshi Tamura
Journal:  J Nutr Metab       Date:  2016-01-19

Review 8.  Oxidative Stress and Dietary Fat Type in Relation to Periodontal Disease.

Authors:  Alfonso Varela-López; José L Quiles; Mario Cordero; Francesca Giampieri; Pedro Bullón
Journal:  Antioxidants (Basel)       Date:  2015-04-28

9.  Effects of conventional heating on the stability of major olive oil phenolic compounds by tandem mass spectrometry and isotope dilution assay.

Authors:  Mohamed Attya; Hicham Benabdelkamel; Enzo Perri; Anna Russo; Giovanni Sindona
Journal:  Molecules       Date:  2010-12-01       Impact factor: 4.411

10.  Antioxidant Effects of a Hydroxytyrosol-Based Pharmaceutical Formulation on Body Composition, Metabolic State, and Gene Expression: A Randomized Double-Blinded, Placebo-Controlled Crossover Trial.

Authors:  Carmela Colica; Laura Di Renzo; Domenico Trombetta; Antonella Smeriglio; Sergio Bernardini; Giorgia Cioccoloni; Renata Costa de Miranda; Paola Gualtieri; Paola Sinibaldi Salimei; Antonino De Lorenzo
Journal:  Oxid Med Cell Longev       Date:  2017-08-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.